HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
31 hedge funds and large institutions have $9.74M invested in Hepion Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
31
Holding in Top 10
–
Calls
$678K
Puts
$56K
Top Buyers
| 1 | +$98.8K | |
| 2 | +$37.4K | |
| 3 | +$33.5K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$10.3K |
| 5 |
PFS
Prospera Financial Services
Dallas,
Texas
|
+$10K |
Top Sellers
| 1 | -$57K | |
| 2 | -$56K | |
| 3 | -$52.2K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$35K |
| 5 |
Two Sigma Advisers
New York
|
-$32.3K |